New shot shows promise for tough eczema cases

NCT ID NCT05932654

Completed Symptom relief Sponsor: Biosion, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an experimental drug called BSI-045B in 22 adults with moderate to severe atopic dermatitis (eczema). Participants received injections weekly for 4 weeks, then every 2 weeks up to 24 weeks. The main goals were to see if the drug safely reduces eczema severity by at least 75% and to monitor side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATOPIC DERMATITIS

Contacts and locations

Show contact details

Locations

Accellacare - Cary

Cary, North Carolina, 27518, United States
Accellacare - Raleigh

Raleigh, North Carolina, 27609, United States
Accellacare-Wilmington

Wilmington, North Carolina, 28411, United States
Advanced Medical Research - Medical Dermatology Specialists

Sandy Springs, Georgia, 30328, United States
Allcutis Research - Beverly, MA

Beverly, Massachusetts, 01915, United States
Beacon Clinical Research

Quincy, Massachusetts, 02169, United States
Center for Clinical Studies - Webster

Webster, Texas, 77598, United States
Center for Dermatology Clinical Research

Fremont, California, 94538, United States
Dawes Fretzin Clinical Research

Indianapolis, Indiana, 46250, United States
Dermatology Specialists of Spokane

Spokane, Washington, 99202, United States
First OC Dermatology - Fountain Valley

Fountain Valley, California, 92708, United States
Paddington Testing Company

Philadelphia, Pennsylvania, 19103, United States
Profound Research LLC - Nashville - Corporate

Oceanside, California, 92056, United States
Sadick Research Group

New York, New York, 10075, United States
Skin Sciences/Derm Research Pllc.

Louisville, Kentucky, 40217, United States
The George Washington University School of Medicine and Health Science

Washington D.C., District of Columbia, 20037, United States
Wright State Physicians Health Center

Fairborn, Ohio, 45324, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.